Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients
[摘要] We investigated factors that physicians consider of most importance in the selection of second line tyrosine kinase inhibitors treatments (TKIs) in chronic myeloid leukemia patients (CML).
[发布日期] 2017-10-18 [发布机构]
[效力级别] [学科分类]
[关键词] Chronic myeloid leukemia;Line of therapy;Tyrosine Kinase inhibitors [时效性]
